MAAT INDEX

CLAIM #3166 · Abbott Laboratories (ABT) · 2024Q2 earnings call · Jul 18, 2024 · due Dec 31, 2025

So yes, we feel good about our ability... do I think that we can continue to deliver this top tier performance throughout this year and into next year? Yes, I absolutely do, because of, one, what we’ve built, and then just the evidence and the proof points that we’ve been able to reliably and sustainably deliver that.

Robert Ford · CEO

PENDING
graded after results covering Dec 31, 2025 are reported

Verify independently

SEC filings for ABT · Claim quote is verbatim from the 2024Q2 earnings call.